[Multiple BCG-induced ulcers after subcutaneous vaccination in the framework of immunochemotherapy in malignant melanoma].
Immunochemotherapy combining dacarbazine with BCG is a possible therapeutic method for the adjuvant treatment of malignant melanomas. The routes of application of BCG, however, vary. As the case of a 61-year-old female shows, subcutaneous injection can lead to severe ulcerations, which respond to tuberculostatic therapy. Therefore scarifications seems to be preferable.
Korting
H C
HC
Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.
Strasser
S
S
Konz
B
B
D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008545:Melanoma / Q000188:drug therapy / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy / Q000628:therapy*; D012883:Skin Ulcer / Q000209:etiology*
D001500:BCG Vaccine; D003606:Dacarbazine
Multiple BCG-Ulzera nach subkutaner Impfstoffapplikation im Rahmen der Immunochemotherapie des malignen Melanoms.